Trichuris Suis Ova in Autism Spectrum Disorders
Phase of Trial: Phase I
Latest Information Update: 30 Jun 2018
At a glance
- Drugs Trichuris suis ova (Primary)
- Indications Autistic disorder
- Focus Therapeutic Use
- 26 Jun 2014 Primary endpoint (Aberrant Behavior Checklist - irritability) has not been met, as reported in a Coronado Biosciences media release.
- 26 Jun 2014 Results will be presented at the 27th Annual Congress of the European College of Neuropsychopharmacology.
- 26 Jun 2014 Status changed from active, no longer recruiting to completed, based on a Coronado Biosciences media release.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History